| DC9469 |
Azatadine (dimaleate) |
Azatadine dimaleate is an histamine and cholinergic inhibitor with IC50 of 6.5 nM and 10 nM, respectively.
|
|
| DC7572 |
AZD1981
Featured
|
AZD1981 is a potent, selective CRTh2 (DP2) receptor antagonist with IC50 of 4 nM, showing >1000-fold selectivity over more than 340 other enzymes and receptors, including DP1 |
|
| DC10724 |
AZD2098
Featured
|
AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor, used for asthma research. |
|
| DC10739 |
AZD4635
Featured
|
AZD4635 is a novel adenosine 2A receptor (A2AR) inhibitor with a Ki of 1.7 nM. |
|
| DC10773 |
AZD5069
Featured
|
AZD-5069 is a potent and selective CXCR2 antagonist with the potential to inhibit neutrophil migration into the airways in patients with COPD. |
|
| DC9130 |
Azelastine HCl |
Azelastine HCl is a potent, second-generation, selective, histamine antagonist. |
|
| DC4210 |
Azilsartan kamedoxomil
Featured
|
Azilsartan medoxomil is an angiotensin II receptor antagonist indicated for the treatment of mild to moderate essential hypertension. |
|
| DCAPI1469 |
azilsartan
Featured
|
Azilsartan(TAK-536) is a specific and potent angiotensin II type 1 receptor antagonist with IC50 of 2.6 nM. |
|
| DC11516 |
Balovaptan
Featured
|
Balovaptan (RG7314, RG-7314) is a potent, selective vasopressin-1 receptor antagonist.. |
|
| DC9117 |
Bambuterol HCl |
Bambuterol Hcl is a long acting beta-adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline. |
|
| DC8298 |
BAN ORL 24
Featured
|
BAN ORL 24 is a potent, selective, competitive ORL1 non-peptide agonist. Displays 1000-fold selectivity over classical opioid receptors. |
|
| DC10385 |
BAR501
Featured
|
BAR501 is a potent and selective agonist of GPBAR1 with an EC50 of 1 μM. |
|
| DC10021 |
Batefenterol
Featured
|
Batefenterol（GSK961081，TD-5959）is a Muscarinic Antagonist and β2-Agonist possessing both muscarinic antagonist (MA) and β2-adrenoceptor agonist (BA) properties (MABA). |
|
| DC9783 |
Bay 59-3074
Featured
|
Bay 59-3074 is a novel CB1/CB2 receptor partial agonist (Ki values are 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively). |
|
| DC8313 |
BD1047.2HBr
Featured
|
BD 1047 dihydrobromide is a selective antagonist of σ receptors. |
|
| DC10280 |
BD1063 dhydrochloride
Featured
|
BD1063 dhydrochloride is a potent and selective sigma 1 receptor antagonist. |
|
| DC12290 |
Befiradol hydrochloride (F 13640 hydrochloride) |
Befiradol hydrochloride is a selective 5-HT1A receptor agonist. |
|
| DCAPI1500 |
Bepotastine Besilate
Featured
|
Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist. |
|
| DC8898 |
Bepotastine
Featured
|
Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. |
|
| DC8967 |
Betahistine Dihydrochloride |
Betahistine Dihydrochloride is a histamine H3 receptors inhibitor used as an antivertigo drug. |
|
| DC8830 |
Betahistine
Featured
|
Betahistine is a strong affinity histamine H3 receptor antagonist and weak affinity agonist of histamine H1 receptors. |
|
| DC9426 |
B-HT 920 |
B-HT 920(Talipexole 2Hcl) is a dopamine D2 receptor agonist, α2-adrenoceptor agonist and 5-HT3 receptor antagonist, which displays antiParkinsonian activity.
|
|
| DC9670 |
BIBS39
Featured
|
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist. |
|
| DC7995 |
Bilastine
Featured
|
Bilastine is a selective histamine H1 receptor antagonist used for treatment of allergic rhinoconjunctivitis and urticaria. |
|
| DCAPI1079 |
Bimatoprost
Featured
|
Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. |
|
| DC11003 |
BL5923 |
BL5923 (BL-5923) is a potent, highly specific, orally available inhibitor of CCR1 with IC50 of 20.4 and 22.8 nM for human and mouse CCR1, resepctively. |
|
| DC7087 |
Blonanserin(AD-5423) |
Blonanserin(AD-5423) is a D2/5-HT2 receptor antagonist, atypical antipsychotic. |
|
| DC7840 |
BML-190
Featured
|
BML-190 is an indomethacin morpholinylamide which functions as a selective inverse agonist of the human cannabinoid CB2 receptor. |
|
| DC10459 |
BMS-986020
Featured
|
BMS-986020 is an LPA1 antagonist. |
|
| DC11923 |
BMS-986120
Featured
|
BMS-986120 (BMS986120) is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4. |
|
